Cytotoxic T-lymphocyte protein 4 — Drug Target
3 drugs
2 marketed
All drugs that target Cytotoxic T-lymphocyte protein 4 — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
CTLA-4-directed Blocking Antibody [EPC] · CTLA-4-directed Blocking Antibody
Marketed (2)
- Yervoy · Bristol-Myers Squibb · Oncology
- IMJUDO · ASTRAZENECA AB · CTLA-4-directed Blocking Antibody [EPC] · Oncology